10.1097/FBP.0000000000000609 13 EdvardssonC
Retatrutide does not yet have a published head-to-head trial comparing it to the other two drugs
According to the Rybelsus Summary of Product Characteristics (SmPC) published on the Electronic Medicines Compendium (EMC), oral bioavailability remains relatively low compared to the injectable form, and the tablet must be taken on an empty stomach with no more than half a glass of water (approximately 120 ml), with the patient remaining fasting for at least 30 minutes afterwards, to maximise absorption
For the study, researchers conducted a web-based analysis of six GLP-1 receptor agonists (three with a once-weekly dosing schedule and three with a once-daily dosing schedule) on PubMed
Current retatrutide availability is limited to research peptide vendors and some compounding pharmacy sources
The Importance of Long-Term Treatment Sustaining weight loss typically requires continued use of GLP-1 medications , combined with long-term lifestyle changes